Thyrotropin-releasing hormone (trh) or thyrotropin-releasing factor (trf) or thyroliberin or protirelin
- Level
- Commodity
- Parent
- 51181600
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51181621This classification denotes a hypothalmic hormone with the molecular formula C16H22N6O4, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier 5Y5F15120W, chemically known as l-prolinamide, 5-oxo-l-prolyl-l-histidyl- but more generally known as protirelin, which bears U.S. National Institutes of Health Compound Identifier 32281. The European Medicines Agency schedules Protirelin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10142MIG. The term PROTIRELIN is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 28, No. 10 1974, List 14). The World Health Organization schedules protirelin in its Anatomical Therapeutic Chemical (ATC) Classification. PROTIRELIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. SMILES: C1CC(N(C1)C(=O)C(CC2=CN=CN2)NC(=O)C3CCC(=O)N3)C(=O)O.
Same parent
Under 51181600 · 29Activities that produce or sell this
KBLI · 8Inherited from family 51180000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.